Torben Nissen
Directeur Général chez Repertoire Immune Medicines, Inc.
Fortune : - $ au 31/12/2023
Postes actifs de Torben Nissen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | - | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Directeur Général | 06/11/2022 | - |
Historique de carrière de Torben Nissen
Anciens postes connus de Torben Nissen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AXCA HEALPAR | Directeur/Membre du Conseil | 10/10/2022 | 01/11/2023 |
| Independent Dir/Board Member | 10/10/2022 | 01/11/2023 | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/08/2018 | 01/12/2021 |
| RUBIUS THERAPEUTICS | Directeur/Membre du Conseil | 01/11/2016 | 01/08/2018 |
| President | 01/11/2016 | 24/07/2019 | |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2014 | 01/11/2016 |
| Centers for Therapeutic Innovation | Directeur/Membre du Conseil | 01/07/2011 | 01/01/2014 |
| Directeur des opérations | 01/07/2011 | 01/01/2014 | |
| ASCENDIS PHARMA A/S | Directeur des opérations | 22/06/2009 | 01/06/2011 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Torben Nissen
| Technical University of Denmark | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
| Danemark | 4 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
Sectorielle
| Health Technology | 8 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| PFIZER, INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| Entreprise privées | 7 |
|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Centers for Therapeutic Innovation | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- Torben Nissen
- Expérience
